LIVE FROM THE DATABASETRANSACTIONS 362,114COMPANIES 5,761LATEST TRADE Oct 16UPDATED Oct 16, 09:12 PM
VTGNCIK 0001411685

Vistagen Therapeutics, Inc.

14 transactions by 7 insiders, from December 31, 2025 to July 29, 2026.

Transactions
147 insiders
Bought · P
Nonenobody bought on the open market
Sold · S
Nonenobody sold on the open market
Net
+$0net buying

Officers and directors

People inside the company. What they do with their own shares is the reason this data exists.

InsiderTradesPlannedBoughtSold
Reid G. AdlerGC3———
Shawn SinghCEO3———
Joshua S. PrinceCOO3———
Nick B. TresslerCFO2———
Elissa S. CoteChief1———
Angel S. AngelovCMO1———
Douglas J. WilliamsonDir1———

All transactions

14 in total, newest filings first.

InsiderDateCodeSharesPriceValue
Douglas J. WilliamsonDirDERIVJul 29A40,826$0.00—?
Nick B. TresslerCFOJun 30A11,712$0.19$2K
Shawn SinghCEOJun 30A36,818$0.19$7K
Reid G. AdlerGCJun 30A36,818$0.19$7K
Angel S. AngelovCMODERIVMay 18A150,000——
Nick B. TresslerCFODERIVApr 7A75,000$0.00—?
Shawn SinghCEODERIVApr 7A71,268$0.00—?
Shawn SinghCEODERIVApr 7A3,732$0.00—?
Joshua S. PrinceCOODERIVApr 7A56,248$0.00—?
Joshua S. PrinceCOODERIVApr 7A18,752$0.00—?
Elissa S. CoteChiefDERIVApr 7A75,000$0.00—?
Reid G. AdlerGCDERIVApr 7A56,247$0.00—?
Reid G. AdlerGCDERIVApr 7A18,753$0.00—?
Joshua S. PrinceCOODec 31A4,386$0.56$2K